Guidelines for antithrombotic therapy for the treatment of venous thromboembolism (VTE), developed in 2001 by the Sixth American College of Chest Physicians (ACCP), state that patients with acute VTE should be treated with low-molecular-weight heparin, unfractionated intravenous heparin, or adjusted-dose subcutaneous heparin